Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection - Concepedia

Concepedia

Publication | Closed Access

Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection

91

Citations

9

References

2011

Year

Richard Elion, Calvin Cohen, Joseph Gathe, Peter Shalit, Trevor Hawkins, Hui C. Liu, Anita Mathias, Steven L. Chuck, Brian P. Kearney, David R. Warren

Abstract

Using cobicistat and ritonavir as pharmacoenhancers for atazanavir and administered with emtricitabine/tenofovir df achieved comparable rates of virologic suppression and CD4 cell count increase with satisfactory safety profiles.

References

	Year	Citations

Page 1